Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

BACKGROUND: Psilocybin, the primary psychoactive component of psychedelic ‘magic mushrooms’, may have potential for treating depressive symptoms, and consequent applications for bipolar disorder (BD). Knowledge of the risks and benefits of psilocybin in BD is limited to case studies. AIM: To support...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Emma, Sakai, Kimberly, Ashtari, Amir, Pleet, Mollie, Michalak, Erin E, Woolley, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834328/
https://www.ncbi.nlm.nih.gov/pubmed/36515370
http://dx.doi.org/10.1177/02698811221131997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834328/
https://www.ncbi.nlm.nih.gov/pubmed/36515370
http://dx.doi.org/10.1177/02698811221131997

Ejemplares similares